SAN DIEGO, April 03, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the home, today announced its home ...

(RTTNews) - ResMed Inc.(RMD), announced Thursday that its NightOwl home sleep apnea test or HSAT is now available across the United States, providing a simple and effective at-home diagnostic solution ...

Resmed is making another strategic investment in U.S.-based manufacturing and distribution, this time in Indianapolis. The move aims to position the company’s inventory of CPAP devices ...

ResMed remains one of the key leaders of sleep apnoea treatment. We expect the company to deliver solid returns in the long run, underpinned by its innovative capabilities. ResMed focuses on ...

Sleep has never come easy for me -- quality sleep, that is. I'm a light sleeper, and I usually find myself wide awake every few hours throughout the night, staring at the ceiling as I wonder why sleep ...

SAN DIEGO, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the home, today announced the ...

Analysts expect a negative impact on ResMed Inc. (RMD) after privately held pharmaceutical company and rival Apnimed, Inc. announced positive results from its late-stage clinical trial evaluating the ...

Resmed Inc (($RMD)) announced an update on their ongoing clinical study. Study Overview: ResMed Inc. is conducting a study titled ‘Nyx3 Eye Mask ...